BM Kali Phos (kali phosphoricum) NDC 85816-1006

NDC codes

FDA NDC Directory

Product NDC (as listed)85816-1006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85816-1006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85816-1006-1	85816100601	30000 mg in 1 BOTTLE, GLASS (85816-1006-1)Marketed from Jan 1, 2015
85816-1006-2	85816100602	500000 mg in 1 JAR (85816-1006-2)Marketed from Jan 1, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BM Kali Phos
Generic name (nonproprietary): kali phosphoricum
Active ingredients: Potassium phosphate, Dibasic — 6 [hp_X]/60mg
Dosage form: Tablet
Route: Oral
Labeler: BM Private Limited
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2015
Listing expires: Dec 31, 2026
Identifiers: Product ID 85816-1006_44f9f008-2021-a802-e063-6394a90a26f9SPL ID 44f9f008-2021-a802-e063-6394a90a26f9SPL set ID 37b18b58-260c-9bad-e063-6394a90acfaaUNII CI71S98N1Z

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485816100601 followed by a unit qualifier and the quantity

Package 85816-1006-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 2, 2025.

Indications (excerpt from the label)

Uses See the leaflet enclosed for detail.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)